Validated Biomarkers Lacking for Ocular Allergy, Dry Eye Disease
Clinicians have resources available to them to assist in identifying ocular surface biomarkers, but a need exists for a universal standard.
Allergy
Topical Therapeutic Effective in Alleviating Allergic Conjunctivitis Symptoms
The reproxalap treatment may potentially address real-world clinical challenges for patients with allergic conjunctivitis.
Ocular Surface Dysbiosis Associated With Allergic Conjunctival Diseases, Tacrolimus
Researchers cannot conclusively determine whether allergic conjunctival disease or tacrolimus treatmentents play a more significant role in ocular surface dysbiosis.
Investigators Review Tolerability of Over-The-Counter Ocular Allergy Drops
The researchers suggested patients may be more compliant using 0.7% olopatadine.
Allergic Reactions to mRNA COVID-19 Vaccines Characterized
Women and those with a previous history of allergy seem to have an increased risk for allergy to mRNA COVID-19 vaccines.
Allergic Conjunctivitis Lowers Children’s Quality of Life
Corneal allergy complications in children can even lower their parents’ quality of life.
Tacrolimus A Potential Alternative to Cyclosporine in Severe Vernal Keratoconjunctivitis
A study supports the use of a calcineurin inhibitor for severe ocular allergies.
Several Topical Meds Can Lead to Allergic Contact Dermatitis
Previously unrecognized pathogenic mechanisms involving ocular contact dermatitis has driven new approaches to control the inflammatory process.
- Loading...
Loading...
Next post in Cornea & Ocular Surface
Loading... 
Loading...